Article
Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants.
The Journal of allergy and clinical immunology - 1 Jan 2025
Santisteban Ines, Arredondo-Vega Francisco X, Bali Pawan, Dalgic Busra, Lee Hyun Ho, Kim Minsoo, Hermanson Jake, Tarrant Teresa K, Hershfield Michael S
Abstract excerpt
BACKGROUND: Deficiency of adenosine deaminase (ADA or ADA1) has broad clinical and genetic heterogeneity. Screening techniques can identify asymptomatic infants whose phenotype and prognosis are indeterminate, and who may carry ADA variants of unknown significance. OBJECTIVE: We systematically assessed the pathogenic potential of rare ADA missense variants to better define the relationship of genotype to red...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
